N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1

Kun Yang, Ryan Huang, Haruhiko Fujihira, Tadashi Suzuki, Nan Yan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Mutations in the NGLY1 (N-glycanase 1) gene, encoding an evolutionarily conserved deglycosylation enzyme, are associated with a rare congenital disorder leading to global developmental delay and neurological abnormalities. The molecular mechanism of the NGLY1 disease and its function in tissue and immune homeostasis remain unknown. Here, we find that NGLY1-deficient human and mouse cells chronically activate cytosolic nucleic acid-sensing pathways, leading to elevated interferon gene signature. We also find that cellular clearance of damaged mitochondria by mitophagy is impaired in the absence of NGLY1, resulting in severely fragmented mitochondria and activation of cGAS-STING as well as MDA5-MAVS pathways. Furthermore, we show that NGLY1 regulates mitochondrial homeostasis through transcriptional factor NRF1. Remarkably, pharmacological activation of a homologous but nonglycosylated transcriptional factor NRF2 restores mitochondrial homeostasis and suppresses immune gene activation in NGLY1-deficient cells. Together, our findings reveal novel functions of the NGLY1-NRF1 pathway in mitochondrial homeostasis and inflammation and uncover an unexpected therapeutic strategy using pharmacological activators of NRF2 for treating mitochondrial and immune dysregulation.

Original languageEnglish (US)
Pages (from-to)2600-2616
Number of pages17
JournalThe Journal of experimental medicine
Volume215
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
Homeostasis
Inflammation
Mitochondria
Mitochondrial Degradation
Pharmacology
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Nucleic Acids
Interferons
Transcriptional Activation
Genes
Mutation
Enzymes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1. / Yang, Kun; Huang, Ryan; Fujihira, Haruhiko; Suzuki, Tadashi; Yan, Nan.

In: The Journal of experimental medicine, Vol. 215, No. 10, 01.10.2018, p. 2600-2616.

Research output: Contribution to journalArticle

Yang, Kun ; Huang, Ryan ; Fujihira, Haruhiko ; Suzuki, Tadashi ; Yan, Nan. / N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1. In: The Journal of experimental medicine. 2018 ; Vol. 215, No. 10. pp. 2600-2616.
@article{4bda8a4b205546b08ed37506af6166d6,
title = "N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1",
abstract = "Mutations in the NGLY1 (N-glycanase 1) gene, encoding an evolutionarily conserved deglycosylation enzyme, are associated with a rare congenital disorder leading to global developmental delay and neurological abnormalities. The molecular mechanism of the NGLY1 disease and its function in tissue and immune homeostasis remain unknown. Here, we find that NGLY1-deficient human and mouse cells chronically activate cytosolic nucleic acid-sensing pathways, leading to elevated interferon gene signature. We also find that cellular clearance of damaged mitochondria by mitophagy is impaired in the absence of NGLY1, resulting in severely fragmented mitochondria and activation of cGAS-STING as well as MDA5-MAVS pathways. Furthermore, we show that NGLY1 regulates mitochondrial homeostasis through transcriptional factor NRF1. Remarkably, pharmacological activation of a homologous but nonglycosylated transcriptional factor NRF2 restores mitochondrial homeostasis and suppresses immune gene activation in NGLY1-deficient cells. Together, our findings reveal novel functions of the NGLY1-NRF1 pathway in mitochondrial homeostasis and inflammation and uncover an unexpected therapeutic strategy using pharmacological activators of NRF2 for treating mitochondrial and immune dysregulation.",
author = "Kun Yang and Ryan Huang and Haruhiko Fujihira and Tadashi Suzuki and Nan Yan",
year = "2018",
month = "10",
day = "1",
doi = "10.1084/jem.20180783",
language = "English (US)",
volume = "215",
pages = "2600--2616",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "10",

}

TY - JOUR

T1 - N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1

AU - Yang, Kun

AU - Huang, Ryan

AU - Fujihira, Haruhiko

AU - Suzuki, Tadashi

AU - Yan, Nan

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Mutations in the NGLY1 (N-glycanase 1) gene, encoding an evolutionarily conserved deglycosylation enzyme, are associated with a rare congenital disorder leading to global developmental delay and neurological abnormalities. The molecular mechanism of the NGLY1 disease and its function in tissue and immune homeostasis remain unknown. Here, we find that NGLY1-deficient human and mouse cells chronically activate cytosolic nucleic acid-sensing pathways, leading to elevated interferon gene signature. We also find that cellular clearance of damaged mitochondria by mitophagy is impaired in the absence of NGLY1, resulting in severely fragmented mitochondria and activation of cGAS-STING as well as MDA5-MAVS pathways. Furthermore, we show that NGLY1 regulates mitochondrial homeostasis through transcriptional factor NRF1. Remarkably, pharmacological activation of a homologous but nonglycosylated transcriptional factor NRF2 restores mitochondrial homeostasis and suppresses immune gene activation in NGLY1-deficient cells. Together, our findings reveal novel functions of the NGLY1-NRF1 pathway in mitochondrial homeostasis and inflammation and uncover an unexpected therapeutic strategy using pharmacological activators of NRF2 for treating mitochondrial and immune dysregulation.

AB - Mutations in the NGLY1 (N-glycanase 1) gene, encoding an evolutionarily conserved deglycosylation enzyme, are associated with a rare congenital disorder leading to global developmental delay and neurological abnormalities. The molecular mechanism of the NGLY1 disease and its function in tissue and immune homeostasis remain unknown. Here, we find that NGLY1-deficient human and mouse cells chronically activate cytosolic nucleic acid-sensing pathways, leading to elevated interferon gene signature. We also find that cellular clearance of damaged mitochondria by mitophagy is impaired in the absence of NGLY1, resulting in severely fragmented mitochondria and activation of cGAS-STING as well as MDA5-MAVS pathways. Furthermore, we show that NGLY1 regulates mitochondrial homeostasis through transcriptional factor NRF1. Remarkably, pharmacological activation of a homologous but nonglycosylated transcriptional factor NRF2 restores mitochondrial homeostasis and suppresses immune gene activation in NGLY1-deficient cells. Together, our findings reveal novel functions of the NGLY1-NRF1 pathway in mitochondrial homeostasis and inflammation and uncover an unexpected therapeutic strategy using pharmacological activators of NRF2 for treating mitochondrial and immune dysregulation.

UR - http://www.scopus.com/inward/record.url?scp=85054091052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054091052&partnerID=8YFLogxK

U2 - 10.1084/jem.20180783

DO - 10.1084/jem.20180783

M3 - Article

VL - 215

SP - 2600

EP - 2616

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 10

ER -